Trial intelligence / Profile preview

Everolimus vs Mycophenolate Sodium in Kidney Transplant Recipients

NCT01927588Phase 4Unknown

Sponsor
Fundação Pró-Rim
Start
Aug 2013
Primary completion
Nov 2015
Modality
Small Molecules
01

Overview

A Phase 4 trial of everolimus in kidney transplant rejection, sponsored by Fundação Pró-Rim. Status: unknown.

02

Drugs

everolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT01927588.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01927588.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call